Medical Blog About Treatment Abroad

Breast cancer is the most commonly diagnosed cancer worldwide, with 2.3 million new cases and nearly 670,000 deaths reported in 2022. According to the World Health Organization, the global burden is expected to rise by almost 40% by 2050, reaching over 3.2 million new cases annually. Women in high-income countries have about a 1 in 12...

Pancreatic cancer is one of the most aggressive types of cancer, with a survival rate of only 13% due to late diagnoses and ineffective response to traditional methods of treatment, including chemotherapy and radiation therapy. Pancreatic cancer is infamous for its resistance to conventional cancer treatment, fast development...

Breast cancer immunotherapy represents a groundbreaking advancement in oncology, encompassing various innovative approaches to cancer treatment. German clinics are at the forefront of implementing these advanced therapies, from immune checkpoint inhibitors to dendritic cell vaccines – the latter made possible by Ralph Steinman... 

Breast cancer remains one of the most common and challenging diseases affecting women worldwide. According to the breast cancer statistics provided by the World Health Organization, more than 2.3 million women were diagnosed with breast cancer in 2022, and over 670,000 deaths were attributed to the disease globally.

Ovarian cancer is one of the most common gynecologic cancers, it ranks second in incidence among all types of cancer. It is most often diagnosed in women over 40-45 years old. Screening and increased awareness are crucial in detecting ovarian cancer early before it reaches stage 4, a terminal phase often accompanied by severe pain...

In Germany, prostate cancer is treated in large multidisciplinary university hospitals, as well as specialized centers of prostate cancer treatment and radiation therapy. With over 50 specialized centers achieving 5-year survival rates above 90% for localized disease, Germany offers advanced therapeutic options.

Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old. Favorable treatment outcomes and colon cancer prognosis, even at stage 4 cancer, can be achieved with the usage...

Among middle-aged and elderly men worldwide, prostate cancer (PCa) stands as a significant health threat. The American Cancer Society's prognosis expects around 313,780 new prostate cancer cases in 2025, and a huge number of approximately 35,770 men are expected to die from this disease. This translates to one man being...